Regenerative potential of prostate luminal cells revealed by single-cell analysis
Author(s)
Karthaus, Wouter R; Hofree, Matan; Choi, Danielle; Linton, Eliot L; Turkekul, Mesruh; Bejnood, Alborz; Carver, Brett; Gopalan, Anuradha; Abida, Wassim; Laudone, Vincent; Biton, Moshe; Chaudhary, Ojasvi; Xu, Tianhao; Masilionis, Ignas; Manova, Katia; Mazutis, Linas; Pe’er, Dana; Regev, Aviv; Sawyers, Charles L; ... Show more Show less
DownloadAccepted version (1.109Mb)
Publisher Policy
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
Androgen deprivation is the cornerstone of prostate cancer treatment. It results in involution of the normal gland to ~90% of its original size because of the loss of luminal cells. The prostate regenerates when androgen is restored, a process postulated to involve stem cells. Using single-cel RNA sequencing, we identified a rare luminal population in the mouse prostate that expresses stemlike genes (Sca1 and Psca ) and a large population of differentiated cells (Nkx3.1 , Pbsn ). In organoids and in mice, both populations contribute equally to prostate regeneration, partly through androgen-driven expression of growth factors (Nrg2, Rspo3) by mesenchymal cells acting in a paracrine fashion on luminal cells. Analysis of human prostate tissue revealed similar differentiated and stemlike luminal subpopulations that likewise acquire enhanced regenerative potential after androgen ablation. We propose that prostate regeneration is driven by nearly all persisting luminal cells, not just by rare stem cells. + + + +
Date issued
2020Department
Koch Institute for Integrative Cancer Research at MIT; Massachusetts Institute of Technology. Department of BiologyJournal
Science
Publisher
American Association for the Advancement of Science (AAAS)